| TriMethopriM IMpurity A |
甲氧苄啶杂质A |
213745-86-9 |
| Tofacitinib related coMpound 2 |
托法替尼相关化合物2 |
1629858-78-1 |
| Besifloxacin Impurity F HCl |
贝西沙星杂质F盐酸盐 |
1613314-38-7 |
| Rosuvastatin EP Impurity C |
瑞舒伐他汀EP杂质C |
1620823-61-1 |
| 2-(2-Chloro-6-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2-氯-6-氟苯硼酸频呢醇酯 |
1599432-38-8 |
| Pomalidomide Impurity 10 |
泊马度胺杂质 |
1547162-41-3 |
| Sofosbuvir IMpurity |
索非布韦杂质(索氟布韦杂质) |
1520010-86-9 |
| Ebastine IMpurity G |
依巴斯汀杂质G |
1429071-65-7 |
| Dexlansoprazole Impurity 6 |
地兰索拉唑杂质6 |
1409978-52-4 |
| Darunavir Impurity 19 |
地瑞那韦杂质 19 |
1402142-62-4 |
| Atorvastatin Impurity 28 |
2,2-二氯-1-(4-氟苯基)-2-苯基乙酮 |
1403667-07-1 |
| 2-Amino-7-(chloromethyl)pteridin-4(1H)-one |
叶酸杂质4 |
1391194-56-1 |
| Ketorolac EP IMpurity F |
酮咯酸杂质F |
1391052-68-8 |
| 1-(p-Chloro-α-phenylbenzyl)-4-(phenylsulfonyl)piperazine |
1-(p-Chloro-α-phenylbenzyl)-4-(phenylsulfonyl)piperazine |
1391052-52-0 |
| Oxymetazoline hydrochloride EP impurity A |
Oxymetazoline hydrochloride EP impurity A |
1391194-44-7 |
| Haloperidol EP Impurity E |
氟哌啶醇EP杂质E |
1391054-69-5 |
| 1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-7-hydroxy-1,2,3,4-tetrahydro-\ncarbostyril |
1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-7-hydroxy-1,2,3,4-tetrahydro-\ncarbostyril |
1391054-74-2 |
| 1-cyclopropyl-2-(2-fluorophenyl)ethane-1,2-dione |
普拉格雷二酮 |
1391054-37-7 |
| 17α-[3-Hydroxypropyl]-6β,7β:15β,16β-diMethylen-5β-androstan-5,17β-ol-3-one |
17α-[3-Hydroxypropyl]-6β,7β:15β,16β-diMethylen-5β-androstan-5,17β-ol-3-one |
1357252-81-3 |
| Erlotinib Impurity 36 HCl |
盐酸厄洛替尼杂质36 |
1354727-63-1 |
QQ
